DE68925304D1 - Minimale Derivatisierung von Proteinen - Google Patents

Minimale Derivatisierung von Proteinen

Info

Publication number
DE68925304D1
DE68925304D1 DE68925304T DE68925304T DE68925304D1 DE 68925304 D1 DE68925304 D1 DE 68925304D1 DE 68925304 T DE68925304 T DE 68925304T DE 68925304 T DE68925304 T DE 68925304T DE 68925304 D1 DE68925304 D1 DE 68925304D1
Authority
DE
Germany
Prior art keywords
proteins
derivatization
minimal
minimal derivatization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68925304T
Other languages
English (en)
Other versions
DE68925304T2 (de
Inventor
Alan R Fritzberg
Daniel S Wilbur
Ananthachari Srinivasan
Dennis W Wester
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poniard Pharmaceuticals Inc
Original Assignee
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poniard Pharmaceuticals Inc filed Critical Poniard Pharmaceuticals Inc
Publication of DE68925304D1 publication Critical patent/DE68925304D1/de
Application granted granted Critical
Publication of DE68925304T2 publication Critical patent/DE68925304T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE68925304T 1988-04-29 1989-04-28 Minimale Derivatisierung von Proteinen Expired - Fee Related DE68925304T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/187,714 US5059541A (en) 1988-04-29 1988-04-29 Minimal derivatization of proteins

Publications (2)

Publication Number Publication Date
DE68925304D1 true DE68925304D1 (de) 1996-02-15
DE68925304T2 DE68925304T2 (de) 1996-08-22

Family

ID=22690161

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68925304T Expired - Fee Related DE68925304T2 (de) 1988-04-29 1989-04-28 Minimale Derivatisierung von Proteinen

Country Status (3)

Country Link
US (1) US5059541A (de)
EP (1) EP0339684B1 (de)
DE (1) DE68925304T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091514A (en) * 1987-03-26 1992-02-25 Neorx Corporation Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
AU3177893A (en) * 1991-11-14 1993-06-15 Battelle Memorial Institute Method for diagnosing and treating cancer
US5756825A (en) * 1992-09-08 1998-05-26 Safavy; Ahmad Hydroxamic acid-based bifunctional chelating compounds
US6203775B1 (en) * 1993-03-19 2001-03-20 The General Hospital Corporation Chelating polymers for labeling of proteins
JP4293632B2 (ja) * 1993-11-16 2009-07-08 ブラッコ インターナショナル ベースローテン フェンノートシャップ 固定化標識方法
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
EP2646058A1 (de) 2010-12-03 2013-10-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Mittel zur molekularen bildgebung von serin-protease bei menschlichen pathologien
US8987396B2 (en) 2013-03-15 2015-03-24 Bayer Materialscience Llc Active polymer polyols and a process for their production
EP4252784A3 (de) * 2015-03-06 2024-01-10 Mayo Foundation for Medical Education and Research Verfahren zur zellmarkierungen und medizinische bildgebung

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4272503A (en) * 1978-05-25 1981-06-09 New England Nuclear Corporation Reductant composition for technetium-99m and method for making technetium-99m labelled ligands
US4305922A (en) * 1978-10-04 1981-12-15 University Patents, Inc. Labeling proteins with 99m-Tc by ligand exchange
US4460561A (en) * 1980-03-03 1984-07-17 Goldenberg M David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4361544A (en) * 1980-03-03 1982-11-30 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4444744A (en) * 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4460559A (en) * 1980-03-03 1984-07-17 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4348376A (en) * 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody
US4421735A (en) * 1980-04-17 1983-12-20 The Massachusetts General Hospital Radiolabeled diagnostic compositions and method for making the same
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4668503A (en) * 1982-07-26 1987-05-26 Trustees Of University Of Massachusetts Process for labeling amines with 99m Tc
US4741900A (en) * 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
US4624846A (en) * 1983-07-29 1986-11-25 Immunomedics, Inc. Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
CA1260827A (en) * 1984-08-31 1989-09-26 Richard C. Siegel Antibody-metal ion complexes
US4824986A (en) * 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
EP0203764B1 (de) * 1985-05-17 1993-03-24 Neorx Corporation Radiohalogenierte kleine Moleküle für das Markieren von Proteinen
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
EP0284071B1 (de) * 1987-03-26 1994-06-08 Neorx Corporation Metall-Radionuklid-markierte Proteine und Glykoproteine zur Diagnose und Therapie
CA1335725C (en) * 1987-09-25 1995-05-30 Stephen W. Hadley Method of diagnosing blood clots using fibrin-binding proteins

Also Published As

Publication number Publication date
EP0339684A3 (de) 1992-04-08
DE68925304T2 (de) 1996-08-22
US5059541A (en) 1991-10-22
EP0339684B1 (de) 1996-01-03
EP0339684A2 (de) 1989-11-02

Similar Documents

Publication Publication Date Title
DK540289A (da) Protein
DK299087D0 (da) Proteins and derivatives thereof
DK552285A (da) Proteinkonjugat
DE3855085D1 (de) Querverbindung von Imidophenylaminen
DK606485D0 (da) Proteinhydrolysat
DK224886D0 (da) Proteinbestemmelse
DK275788D0 (da) Protein
DK353788A (da) Polypeptidderivater
DE69117266D1 (de) Modifizierung von gelatine
DK600586A (da) Protein
DE68925304D1 (de) Minimale Derivatisierung von Proteinen
DE68923623D1 (de) Durchführung von teileprogrammen.
DK395288D0 (da) Proteiner
DK0406598T3 (da) Proteinhydrolyse
DK419486D0 (da) Proteinekspression
DK355189D0 (da) Nye proteiner
DK345087D0 (da) Protein
DK555189D0 (da) Proteinprodukt
DK354989D0 (da) Modificerede proteiner
DK284489A (da) Fusionsproteiner
KR900015532U (ko) 일부인
DK178089D0 (da) Proteinoprensningsfremgangsmaade
IT8847653A0 (it) Sizzante comprendente 5 - idroscomposizione farmaceutica anoressitrpofano
KR900004740U (ko) 일부인
DK51585A (da) Proteinkoncentrater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee